Compare GERN & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GERN | PMT |
|---|---|---|
| Founded | 1990 | 2009 |
| Country | United States | United States |
| Employees | 229 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | N/A | N/A |
| Metric | GERN | PMT |
|---|---|---|
| Price | $1.58 | $11.43 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 4 |
| Target Price | $2.17 | ★ $13.67 |
| AVG Volume (30 Days) | ★ 16.9M | 931.2K |
| Earning Date | 05-06-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 14.15% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $26.91 | N/A |
| Revenue Next Year | $43.75 | $2.29 |
| P/E Ratio | ★ N/A | $12.59 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.04 | $11.17 |
| 52 Week High | $2.01 | $14.87 |
| Indicator | GERN | PMT |
|---|---|---|
| Relative Strength Index (RSI) | 50.64 | 34.42 |
| Support Level | $1.24 | N/A |
| Resistance Level | $1.70 | $12.88 |
| Average True Range (ATR) | 0.11 | 0.28 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 57.81 | 27.96 |
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.